• Explore /
  • Poster
  • / Multicenter randomized phase II study comparing alternate-day oral therapy using S-1 with the standard regimen as a first-line treatment for patients with locally advanced and metastatic pancreatic cancer: PAN-01 study.

Multicenter randomized phase II study comparing alternate-day oral therapy using S-1 with the standard regimen as a first-line treatment for patients with locally advanced and metastatic pancreatic cancer: PAN-01 study.

Abstract Poster

Authors

null

Masayuki Sho

Department of Surgery, Nara Medical University, Kashihara, Japan

Masayuki Sho , Atsushi Shimizu , Hiroaki Yanagimoto , Shoji Nakamori , Takuji Okusaka , Hiroshi Ishii , Masayuki Kitano , Kazuya Sugimori , Hiroyuki Maguchi , Shinichi Ohkawa , Hiroshi Imaoka , Daisuke Hashimoto , Kazuki Ueda , Hiroko Nebiki , Tatsuya Nagakawa , Hiroyuki Isayama , Yasuhiro Hagiwara , Yasuo Ohashi , Tetsuhiko Shirasaka , Hiroki Yamaue

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

UMIN000008604

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4107)

DOI

10.1200/JCO.2016.34.15_suppl.4107

Abstract #

4107

Poster Bd #

99

Abstract Disclosures

Similar Posters

First Author: Xj Xiang

First Author: Dong-Sheng Zhang

First Author: Li-Yuan Bai

First Author: Nai-Jung Chiang